Depressive symptoms in Parkinson's disease are insufficiently but more often treated than in other chronic conditions.
Journal
NPJ Parkinson's disease
ISSN: 2373-8057
Titre abrégé: NPJ Parkinsons Dis
Pays: United States
ID NLM: 101675390
Informations de publication
Date de publication:
14 Jul 2023
14 Jul 2023
Historique:
received:
20
12
2022
accepted:
26
06
2023
medline:
15
7
2023
pubmed:
15
7
2023
entrez:
14
7
2023
Statut:
epublish
Résumé
Depressive symptoms in Parkinson's disease (PD) are multifactorial and are partly linked to the underlying dopaminergic deficit. However, at least a subset of PD patients may exhibit an unspecific depressive reaction to chronic illness. Here, we compared the prevalence and severity of depressive symptoms in PD patients and disease controls (DC). PD patients reported depressive symptoms at similar frequencies as DC but were on antidepressants, especially Mirtazapine, more frequently. Still, in both groups, a high proportion of patients with clinically significant depressive symptoms was not receiving medication. Diagnosis and treatment of depressive symptoms both in PD and DC should be improved.
Identifiants
pubmed: 37452071
doi: 10.1038/s41531-023-00551-8
pii: 10.1038/s41531-023-00551-8
pmc: PMC10349053
doi:
Types de publication
Journal Article
Langues
eng
Pagination
113Investigateurs
Julia Graf
(J)
Nathalie Schell
(N)
Raluca Modreanu
(R)
Barbara Staemmler
(B)
Elena Loewin
(E)
Informations de copyright
© 2023. The Author(s).
Références
Mov Disord. 2008 Jan 30;23(2):183-9; quiz 313
pubmed: 17987654
J Affect Disord. 2012 Jul;139(2):103-12
pubmed: 21794923
J Neurol Neurosurg Psychiatry. 1986 Apr;49(4):381-9
pubmed: 3701347
Qual Life Res. 2013 Sep;22(7):1543-53
pubmed: 23070750
Mov Disord. 2015 Apr;30(4):531-7
pubmed: 25546094
Neuroepidemiology. 2011;37(1):1-10
pubmed: 21757958
Mov Disord. 2011 Aug 1;26(9):1741-4
pubmed: 21442660
Curr Neurol Neurosci Rep. 2013 Dec;13(12):409
pubmed: 24190780
Mov Disord Clin Pract. 2020 Mar 16;7(3):343-345
pubmed: 32258239
Int J Epidemiol. 2013 Feb;42(1):128-128k
pubmed: 23257687
Neurosci Biobehav Rev. 2022 Oct;141:104749
pubmed: 35750224
Mov Disord. 2019 Oct;34(10):1464-1470
pubmed: 31412427
Arch Gen Psychiatry. 1961 Jun;4:561-71
pubmed: 13688369
BMC Neurol. 2017 Jul 1;17(1):126
pubmed: 28666413
J Clin Neurosci. 2018 Jul;53:1-5
pubmed: 29706419
Psychol Med. 1998 May;28(3):551-8
pubmed: 9626712
Front Endocrinol (Lausanne). 2022 May 04;13:863281
pubmed: 35600588
Sci Rep. 2021 Sep 23;11(1):18976
pubmed: 34556776
Lipids Health Dis. 2020 May 19;19(1):97
pubmed: 32430016
Mov Disord. 2007 Sep 15;22(12):1681-8
pubmed: 17534951
Mov Disord Clin Pract. 2016 Jul 18;3(6):538-547
pubmed: 30363567
Clin Neurol Neurosurg. 2006 Jul;108(5):465-9
pubmed: 16150537
J Neurol Sci. 2019 Jul 15;402:81-85
pubmed: 31125734
Mov Disord. 2015 Oct;30(12):1591-601
pubmed: 26474316
Brain Behav. 2021 Aug;11(8):e2228
pubmed: 34124851
J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4
pubmed: 1564476
Drugs Aging. 2022 Jun;39(6):417-439
pubmed: 35705848
Mov Disord. 2007 Apr 15;22(5):666-72
pubmed: 17266084
Mov Disord. 2019 Feb;34(2):180-198
pubmed: 30653247
Mov Disord. 1995 May;10(3):263-6
pubmed: 7544438
J Affect Disord. 2020 Dec 1;277:1038-1044
pubmed: 33065812